Market Dynamics and Generic Entry: Why is Suboxone Being Discontinued in Certain Forms?
•
4 min read
In 2012, the manufacturer of Suboxone announced the voluntary discontinuation of its tablet form, citing concerns over pediatric exposure which were 7.8 to 8.5 times higher than with the film version [1.2.5, 1.2.7]. This move answers the question 'Why is Suboxone being discontinued?' by revealing a pivotal market shift toward newer, patent-protected formulations and, eventually, widespread generic alternatives.
